提亚二醇衍生的共价有机框架宏观超轻型气凝
Haifeng Ji1, Mengke Li1, Gaojie Yan1
1Hebei Key Laboratory of Functional Polymers, Department of Polymer Materials and Engineering, Hebei University of Technology, Tianjin 300401, P. R. China.
研究人员从基于亚醇的共价有机框架 (COF) 开发出一种新的超轻型气凝. 这种新型材料具有显著的机械,热和阻燃性能,以及高效的光催化进化能力.
科学领域:
- 材料科学 材料科学 材料科学
- 化学工程是化学工程的重要组成部分.
- 纳米技术纳米技术
背景情况:
- 将共价有机框架 (COF) 塑造成宏观物体,用于实际应用是一个重大挑战.
- 开发具有可调节性质的先进材料对于技术进步至关重要.
研究的目的:
- 为了合成一种新型的亚醇衍生的COF宏观超轻型气凝 (NNS-VCOF).
- 为了研究NNS-VCOF气凝的物理,热和光催化性能.
主要方法:
- 在2,5-二甲基-1,3,4-亚二醇和三芳香性化物衍生物之间的酸催化阿尔多尔凝结.
- 气凝的密度,机械性能,导热率和阻燃性.
- 在粉末状态下对光催化演变的评估.
主要成果:
- 该NNS-VCOF气凝显示出大约0.020gcm-3.3的超低密度.
- 它具有出色的机械性能 (压缩模量为16.65kPa) 和绝热性 (导热率为0.03270Wm-1K-1).
- 该材料表现出良好的阻燃性和高效的光催化演变,这是由于其独特的结构和特性.
结论:
- 开发的NNS-VCOF气凝是一种有前途的超轻型宏观材料,具有卓越的热性能和机械性能.
- 它独特的异环结构和海绵状结构有助于其卓越的性能.
- 该材料还显示了光催化应用的潜力,特别是在进化的过程中.
更多相关视频
10:23Synthesis and Functionalization of 3D Nano-graphene Materials: Graphene Aerogels and Graphene Macro Assemblies
Published on: November 5, 2015
08:42Microfluidic-based Synthesis of Covalent Organic Frameworks COFs: A Tool for Continuous Production of COF Fibers and Direct Printing on a Surface
Published on: July 10, 2017
相关概念视频
Carboxylic Acid Derivatives: Overview
Structures of Carboxylic Acid Derivatives
Carboxylic acid derivatives contain an acyl group attached to a heteroatom such as chlorine, oxygen, or nitrogen. The carbonyl carbon and oxygen are both sp2-hybridized with an unhybridized p orbital.
The three sp2 orbitals of the carbonyl carbon form three σ bonds, one each with the carbonyl oxygen, the α carbon, and the heteroatom, whereas the other two sp2 orbitals of the carbonyl oxygen are occupied by the lone pairs. Further, the unhybridized p...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Pharmaceutical Equivalents
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
